Literature DB >> 34241550

Radiomic Features at CT Can Distinguish Pancreatic Cancer from Noncancerous Pancreas.

Po-Ting Chen1, Dawei Chang1, Huihsuan Yen1, Kao-Lang Liu1, Su-Yun Huang1, Holger Roth1, Ming-Shiang Wu1, Wei-Chih Liao1, Weichung Wang1.   

Abstract

Purpose To identify distinguishing CT radiomic features of pancreatic ductal adenocarcinoma (PDAC) and to investigate whether radiomic analysis with machine learning can distinguish between patients who have PDAC and those who do not. Materials and Methods This retrospective study included contrast material-enhanced CT images in 436 patients with PDAC and 479 healthy controls from 2012 to 2018 from Taiwan that were randomly divided for training and testing. Another 100 patients with PDAC (enriched for small PDACs) and 100 controls from Taiwan were identified for testing (from 2004 to 2011). An additional 182 patients with PDAC and 82 healthy controls from the United States were randomly divided for training and testing. Images were processed into patches. An XGBoost (https://xgboost.ai/) model was trained to classify patches as cancerous or noncancerous. Patients were classified as either having or not having PDAC on the basis of the proportion of patches classified as cancerous. For both patch-based and patient-based classification, the models were characterized as either a local model (trained on Taiwanese data only) or a generalized model (trained on both Taiwanese and U.S. data). Sensitivity, specificity, and accuracy were calculated for patch- and patient-based analysis for the models. Results The median tumor size was 2.8 cm (interquartile range, 2.0-4.0 cm) in the 536 Taiwanese patients with PDAC (mean age, 65 years ± 12 [standard deviation]; 289 men). Compared with normal pancreas, PDACs had lower values for radiomic features reflecting intensity and higher values for radiomic features reflecting heterogeneity. The performance metrics for the developed generalized model when tested on the Taiwanese and U.S. test data sets, respectively, were as follows: sensitivity, 94.7% (177 of 187) and 80.6% (29 of 36); specificity, 95.4% (187 of 196) and 100% (16 of 16); accuracy, 95.0% (364 of 383) and 86.5% (45 of 52); and area under the curve, 0.98 and 0.91. Conclusion Radiomic analysis with machine learning enabled accurate detection of PDAC at CT and could identify patients with PDAC. Keywords: CT, Computer Aided Diagnosis (CAD), Pancreas, Computer Applications-Detection/Diagnosis Supplemental material is available for this article. © RSNA, 2021.

Entities:  

Keywords:  CT; Computer Aided Diagnosis (CAD); Computer Applications-Detection/Diagnosis; Pancreas

Mesh:

Year:  2021        PMID: 34241550      PMCID: PMC8344348          DOI: 10.1148/rycan.2021210010

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN: 2638-616X


  20 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Pancreatic adenocarcinoma.

Authors:  David P Ryan; Theodore S Hong; Nabeel Bardeesy
Journal:  N Engl J Med       Date:  2014-11-27       Impact factor: 91.245

3.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

Review 4.  Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.

Authors:  John Dewitt; Benedict M Devereaux; Glen A Lehman; Stuart Sherman; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-03       Impact factor: 11.382

5.  Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.

Authors:  Linda C Chu; Seyoun Park; Satomi Kawamoto; Daniel F Fouladi; Shahab Shayesteh; Eva S Zinreich; Jefferson S Graves; Karen M Horton; Ralph H Hruban; Alan L Yuille; Kenneth W Kinzler; Bert Vogelstein; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2019-04-23       Impact factor: 3.959

6.  A prospective evaluation of fatty pancreas by using EUS.

Authors:  Paul S Sepe; Ashray Ohri; Sirish Sanaka; Tyler M Berzin; Sandeep Sekhon; Gayle Bennett; Gaurav Mehta; Ram Chuttani; Robert Kane; Douglas Pleskow; Mandeep S Sawhney
Journal:  Gastrointest Endosc       Date:  2011-05       Impact factor: 9.427

Review 7.  Pancreatic carcinoma: Key-points from diagnosis to treatment.

Authors:  E Frampas; A David; N Regenet; Y Touchefeu; J Meyer; O Morla
Journal:  Diagn Interv Imaging       Date:  2016-08-24       Impact factor: 4.026

Review 8.  Imaging preoperatively for pancreatic adenocarcinoma.

Authors:  Jason Alan Pietryga; Desiree E Morgan
Journal:  J Gastrointest Oncol       Date:  2015-08

9.  Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.

Authors:  Wan-Chen Wu; Chih-Yuan Wang
Journal:  Cardiovasc Diabetol       Date:  2013-05-20       Impact factor: 9.951

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  6 in total

1.  Radiomics for Detection of Pancreas Adenocarcinoma on CT Scans: Impact of Biliary Stents.

Authors:  Garima Suman; Anurima Patra; Sovanlal Mukherjee; Panagiotis Korffiatis; Ajit H Goenka
Journal:  Radiol Imaging Cancer       Date:  2022-01

2.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

Review 3.  Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.

Authors:  Touseef Ahmad Qureshi; Sehrish Javed; Tabasom Sarmadi; Stephen Jacob Pandol; Debiao Li
Journal:  Chin Clin Oncol       Date:  2022-02-09

Review 4.  Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.

Authors:  Kiersten Preuss; Nate Thach; Xiaoying Liang; Michael Baine; Justin Chen; Chi Zhang; Huijing Du; Hongfeng Yu; Chi Lin; Michael A Hollingsworth; Dandan Zheng
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

5.  Detection of Pancreatic Cancer in CT Scan Images Using PSO SVM and Image Processing.

Authors:  Arshiya S Ansari; Abu Sarwar Zamani; Mohammad Sajid Mohammadi; Mahyudin Ritonga; Syed Sohail Ahmed; Devabalan Pounraj; Karthikeyan Kaliyaperumal
Journal:  Biomed Res Int       Date:  2022-07-26       Impact factor: 3.246

6.  Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling.

Authors:  Shuo Wang; Chi Lin; Alexander Kolomaya; Garett P Ostdiek-Wille; Jeffrey Wong; Xiaoyue Cheng; Yu Lei; Chang Liu
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.